Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemocentryx Inc (NQ: CCXI )

26.15 -1.36 (-4.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,344,665
Open 27.77
Bid (Size) 25.00 (5)
Ask (Size) 27.25 (5)
Prev. Close 27.51
Today's Range 25.13 - 27.79
52wk Range 12.71 - 42.16
Shares Outstanding 71,193,352
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
55 Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. 
Via Benzinga

Performance

YTD
-29.42%
-29.42%
1 Month
+16.79%
+16.79%
3 Month
+7.48%
+7.48%
6 Month
-29.17%
-29.17%
1 Year
+89.91%
+89.91%

More News

Read More
Why ChemoCentryx Shares Are Popping Off
Via Benzinga
ChemoCentryx Posts Favorable PK, PD Results Of Oral PD-L1 Inhibitor In Cancer
Via Benzinga
Why ChemoCentryx Shares Are Falling
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
24 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
ChemoCentryx: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
ChemoCentryx's Earnings: A Preview
Via Benzinga
NASDAQ: CCXI Investor Notice: Update in Lawsuit Against ChemoCentryx, Inc. Announced
Via SBWire
Bonds Are Screaming “Recession.” That’s Great News For One Top Sector.
Via InvestorPlace
CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
From Kahn Swick & Foti, LLC
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
ChemoCentryx's Return On Capital Employed Insights
Via Benzinga
See Why Is Stifel Analyst 'Perplexed' After ChemoCentryx Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
28 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.